Friday, May 18, 2018

US FDA News: FDA approves novel preventive treatment for migraine

FDA approves Aimovig for the preventive treatment of migraine. Aimovig works by blocking the activity of a molecule that is involved in migraine attacks.
Read more: FDA approves novel preventive treatment for migraine